| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:CMLD010509;CMLD-010509,CMLD010509
CAS:256497-58-2
Purity:98% Package:5 mg
|
| Company Name: |
RD International Technology Co., Limited
|
| Tel: |
18024082417 |
| Email: |
market@ubiochem.com |
| Products Intro: |
Product Name:CMLD010509
CAS:256497-58-2
Purity:5mg;10mg;50mg;100mg;250mg;500mg;1g Package:5mg;10mg;50mg;100mg;250mg;500mg;1g
|
|
| | CMLD010509 Basic information |
| Product Name: | CMLD010509 | | Synonyms: | CMLD010509;SDS-1-021;CMLD-010509,CMLD010509;1H-Cyclopenta[b]benzofuran-2-carboxamide, 3a-(4-bromophenyl)-2,3,3a,8b-tetrahydro-1,8b-dihydroxy-N,6,8-trimethoxy-3-phenyl-, (1R,2R,3S,3aR,8bS)-rel- | | CAS: | 256497-58-2 | | MF: | C27H26BrNO7 | | MW: | 556.4 | | EINECS: | | | Product Categories: | | | Mol File: | 256497-58-2.mol |  |
| | CMLD010509 Chemical Properties |
| density | 1.519±0.06 g/cm3(Predicted) | | pka | 11.56±0.70(Predicted) |
| | CMLD010509 Usage And Synthesis |
| Description | CMLD010509 is a highly specific inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MYC, MDM2, CCND1, MAF, and MCL-1. |
| | CMLD010509 Preparation Products And Raw materials |
|